Class IITerminatedD-0583-2024
Drug recall · July 10, 2024
Allopurinol Tablets recall
Why: Presence of foreign substance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
- Lots / codes
L2300594
- Quantity
- 20,520 units
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- IL, MS, OH
- Initiated
- June 7, 2024 · Voluntary: Firm initiated
- Classified
- July 3, 2024
- Reported
- July 10, 2024
- Ended
- December 22, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Allopurinol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.